ORIC (STOCKS)
Oric Pharmaceuticals, Inc. Common Stock
$13.410000
-0.340000 (-2.47%)
Prev close: $13.750000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jacob M. Chacko
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,846.07M
- Employees
- 128
- P/E (TTM)
- -10.16
- P/B (TTM)
- 3.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $15.79M |
| Operating Expenses | $156.14M |
| Operating Income/Loss | -$156.14M |
| Income/Loss From Continuing Operations After Tax | -$140.35M |
| Income/Loss From Continuing Operations Before Tax | -$140.35M |
| Net Income/Loss | -$140.35M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$140.35M |
| Net Income/Loss Available To Common Stockholders, Basic | -$140.35M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.32 |
| Diluted Earnings Per Share | -$1.32 |
| Basic Average Shares | 210,687,757 |
| Diluted Average Shares | 210,687,757 |
| Assets | $404.69M |
| Current Assets | $273.70M |
| Noncurrent Assets | $130.99M |
| Fixed Assets | $2.24M |
| Other Non-current Assets | $128.75M |
| Liabilities | $23.43M |
| Current Liabilities | $20.76M |
| Accounts Payable | $3.87M |
| Other Current Liabilities | $16.88M |
| Noncurrent Liabilities | $2.67M |
| Equity | $381.26M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $381.26M |
| Liabilities And Equity | $404.69M |
| Net Cash Flow From Operating Activities | -$111.64M |
| Net Cash Flow From Operating Activities, Continuing | -$111.64M |
| Net Cash Flow From Investing Activities | -$99.66M |
| Net Cash Flow From Investing Activities, Continuing | -$99.66M |
| Net Cash Flow From Financing Activities | $172.92M |
| Net Cash Flow From Financing Activities, Continuing | $172.92M |
| Net Cash Flow | -$38.38M |
| Net Cash Flow, Continuing | -$38.38M |
| Comprehensive Income/Loss | -$141.56M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$141.56M |
| Other Comprehensive Income/Loss | $20.50M |